Criticalkare Pharma

Rebif 44mcg Injection contains the active substance Interferon beta-1a, which is classified as an immunomodulator. Interferons are natural proteins the body produces to fend off infections and diseases. The protein in Rebif 44mcg Injection is identical to the one naturally found in humans. This medication is utilized to treat relapsing forms of multiple sclerosis, an autoimmune condition impacting the central nervous system (brain and spinal cord).
It is not recommended to use Rebif 44mcg injection in children and adolescents due to limited data on its effectiveness and safety in this age group, especially in children below ten years old. Inform your doctor if you are allergic to the Rebif 44mcg injection or any of its ingredients, have severe depression, suicidal thoughts, uncontrolled epilepsy, serious kidney or liver problems, low white blood cell or platelet count, heart problems, or irritation at the injection site. Report any mood changes, suicidal thoughts, or worsening of existing conditions to your doctor. Transparent communication with your doctor about your medical history and medications is crucial for the safe use of Rebif 44mcg Injection.

Uses
Multiple sclerosis

Storage
Store in original sealed packaging to shield from light. Keep in the refrigerator between 2°C and eight °C; do not freeze. Do not use it if the syringe is broken.

Side Effects
Serious allergic reactions like swelling of the face, lips, or tongue, difficulty breathingDepressionLiver problems like yellowing of your skin or the whites of your eyes (jaundice) - Itching all over - Feeling sick, being sick (nausea and vomiting) Easy skin bruisingFlu-like symptoms—headache, muscle aches, chills or a feverLoss of appetiteFeeling weak and tired Difficulty sleeping Runny noseDiarrheaNumbness or tingling of the skinIncreased sweating, night sweatsPain in your muscles, joints, arms, legs or neckInjection site painChanges in the laboratory values of blood cells (RBC, WBC, Platelets) and liver functions

Relibeta 30mcg injection injections contain the active substance Interferon beta-1a, which is classified as an immunomodulator. Interferons are natural proteins the body produces to fend off infections and diseases. The protein in Relibeta 30mcg injection is identical to the one naturally found in humans. This medication is utilized to treat relapsing forms of multiple sclerosis, an autoimmune condition impacting the central nervous system (brain and spinal cord). 
It is not recommended to use Relibeta 30mcg injection in children and adolescents due to limited data on its effectiveness and safety in this age group, especially in children below ten years old. Inform your doctor if you are allergic to interferon beta-1a or any of its ingredients, have severe depression, suicidal thoughts, uncontrolled epilepsy, serious kidney or liver problems, low white blood cell or platelet count, heart problems, or irritation at the injection site. Report any mood changes, suicidal thoughts, or worsening of existing conditions to your doctor. Transparent communication with your doctor about your medical history and medications is crucial for the safe use of Relibeta 30mcg injection.

Uses
Multiple sclerosis

Storage
Store in original sealed packaging to shield from light.Keep in the refrigerator between 2°C and 8°C; do not freeze.Do not use it if the syringe is broken.

Side Effects
Serious allergic reactions like swelling of the face, lips, or tongue, difficulty breathingDepressionLiver problems like yellowing of your skin or the whites of your eyes (jaundice) - Itching all over - Feeling sick, being sick (nausea and vomiting) Easy skin bruisingFlu-like symptoms—headache, muscle aches, chills or a feverLoss of appetiteFeeling weak and tiredDifficulty sleepingRunny noseDiarrheaNumbness or tingling of the skinIncreased sweating, night sweatsPain in your muscles, joints, arms, legs or neckInjection site painChanges in the laboratory values of blood cells (RBC, WBC, Platelets) and liver functions

Tysabri 300mg injection contains an active component such as Natalizumab. This medication is a monoclonal antibody medication used to treat multiple sclerosis (MS) and Crohn's disease. Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system, causing communication problems between the brain and the rest of the body. 
Crohn's disease is a chronic inflammatory condition affecting the gastrointestinal tract. This medication-targeted mechanism of action reduces inflammation by blocking specific immune cell movement, thereby mitigating potential damage to the central nervous system in MS or reducing inflammation in the gut in Crohn's disease. 
By effectively managing disease activity, Tysabri 300mg injection can improve patients' overall quality of life by reducing symptoms, decreasing the frequency of relapses, and potentially delaying disability progression.
Tysabri 300mg injection can cause hypersensitivity reactions in some individuals. Patients with a history of hypersensitivity to this medicine or its components should avoid its use, and individuals at higher risk need screening. This medication is contraindicated in patients with a history of progressive multifocal leukoencephalopathy (PML) or who are positive for the JC virus, as they are at a higher risk of developing PML during treatment. 
It should not be used in patients with active infections, especially serious or opportunistic infections. Its safety and effectiveness in pediatric patients (children and adolescents) have not been fully established. Therefore, its use in this population is generally not recommended.

Uses
Multiple sclerosis (MS)Crohn's disease.

Storage
Store at room temperature, between  2°C to 8°C (36°F to 46°F).Keep away from moisture, heat, and light.It should not be frozen.

Side Effects
Progressive multifocal leukoencephalopathy (PML)Infusion reactionsLiver damageInfectionsHypersensitivityHeadacheFatigueNauseaUpper respiratory tract infections (common cold)Urinary tract infections

Acton prolongatum 60IU injection contains an active component such as Corticotropin. It is a medication primarily used to treat various medical conditions related to the adrenal glands and the production of corticosteroid hormones. This medication manages multiple sclerosis flare-ups, reduces proteinuria in resistant nephrotic syndrome, treats infantile spasms, relieves inflammation and pain in rheumatoid arthritis, addresses systemic lupus erythematosus, treats Addison's disease by replacing deficient hormones, helps adrenal gland function assessment, and supports wound healing.
If you have a known allergy to Acton prolongatum 60IU injection or any of its components, it is important to inform your healthcare provider before starting treatment. It can suppress the immune system, so individuals with systemic fungal infections should not take this medication. Its use might not suit individuals with active systemic viral infections, such as herpes or varicella-zoster virus. It is generally avoided in individuals with skin conditions like widespread psoriasis. This medication should be avoided in individuals with uncontrolled diabetes. Individuals with severe osteoporosis might need to avoid this medication. It is generally recommended to avoid live vaccines while on Acton prolongatum 60IU injection treatment. In both children and older adults, always consult a healthcare provider.

Uses
Adrenal insufficiency (Addison's disease)Infantile spasmsMultiple sclerosis (MS) exacerbationsNephrotic syndromeRheumatoid arthritisSystemic lupus erythematosus (SLE) flaresEosinophilic conditionsWound healing and tissue repair

Storage
Store at room temperature, between 20°C to 25°CKeep away from moisture, heat, and light.It should not be frozen.

Side Effects
Allergic reactionsAdrenal suppressionOsteoporosisEye conditionsGastrointestinal issuesCardiovascular effectsMetabolic effectsCushing's syndromeIncreased appetiteMood changesFluid retentionHigh blood pressureIncreased blood glucoseInsomniaSkin changes